Rajnish Mago, MD, Editor-in-Chief .
Rajeev Mahajan, MBBS Executive Editor.
We are grateful to the other members of the Editorial Board for SimpleandPractical.com (listed alphabetically below) who are internationally recognized as leading experts in psychiatry and in psychopharmacology. The Editorial Board monitors our content to avoid any errors and to suggest improvements.
Chittaranjan Andrade, MD
Dr. Andrade has published 19 books, about 40 book chapters, and has authored or coauthored more than 500 scientific papers in peer-reviewed journals.
In addition to being on the Editorial Board of Simple and Practical Mental Health, Dr. Andrade is a member of the editorial boards of:
1. Journal of Clinical Psychiatry
2. International Journal of Bipolar Disorders
3. Bipolar disorders (Field Editor for Clinical Therapeutics)
4. The Journal of ECT
5. Brain Stimulation
6. Indian Journal of Psychiatry.
Vivien Burt, MD, PhD
Professor Emeritus of Psychiatry
Department of Psychiatry and Biobehavioral Sciences
The David Geffen School of Medicine at UCLA.
Founder and Co-Director, The Women’s Life Center
Resnick UCLA Neuropsychiatric Hospital
Los Angeles, California, USA.
Simple and Practical Mental Health is proud to have Prof. Vivien Burt, MD, PhD, on our Editorial Board as well as one of our Authors.
Dr. Burt has authored numerous articles and book chapters in the field of women’s psychiatry, has coauthored The Clinical Manual for Women’s Mental Health, published by the American Psychiatric Press in May 2008 and is the first author of the chapter on Women’s Mental Health in the American Psychiatric Press Textbook of Psychiatry, published in 2014.
She has been honored with an Outstanding House Staff Teaching Award from the UCLA Neuropsychiatric Institute, both a President’s Award and an Outstanding Achievement Award from the Southern California Psychiatric Society, and the Distinguished Service Award of the UCLA Neuropsychiatric Institute and Hospital, the 2008 Andre Boivin Professorship of the Motherisk Program of The Hospital for Sick Children in Toronto, Canada.
The focus of her activities includes projects in women’s mental health with a particular focus on psychiatric illnesses associated with reproductive transitions.
Leslie Citrome, MD
Dr. Citrome is Clinical Professor of Psychiatry & Behavioral Sciences at New York Medical College in Valhalla, NY, and has a private practice in Pomona, NY.
He completed a Residency and Chief Residency in Psychiatry at the New York University School of Medicine and went on to complete a Masters in Public Health at Columbia University. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology.He is editor in chief of the International Journal of Clinical Practice and the author/co-author of over 400 published research reports, reviews, and book chapters in the biomedical literature. He is the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.
Anita Clayton, MD
Dr. Clayton is Professor and Chair of Psychiatry & Neurobehavioral Sciences and Professor of Clinical Obstetrics & Gynecology at the University of Virginia has focused her research on major depressive disorder, mood disorders associated with reproductive-life events in women, sexual dysfunction related to illness and medications, and treatment of primary sexual disorders. She has published over 160 peer-reviewed papers, and developed and validated several measurement tools including the Changes in Sexual Functioning Questionnaire, Sexual Interest and Desire Inventory, and the Decreased Sexual Desire Screener. She co-edited Women’s Mental Health: A Comprehensive Textbook, and is the author of Satisfaction: Women, Sex, and the Quest for Intimacy for the general public. She has served as President of the International Society for Women’s Sexual Health (ISSWSH), as Vice-Chair for Women’s Sexual Health for the 3rd and 4th International Consultation on Sexual Medicine in 2009 and 2015, and on the Board of Directors and Scientific Program Committee of the American Society of Clinical Psychopharmacology and ISSWSH.
Jose De Leon, MD
1. Professor of Psychiatry, University of Kentucky College of Medicine, Lexington, Kentucky, USA
2. Director, Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, USA
3. Director, Residency Education, Eastern State Hospital, Lexington, Kentucky, USA
4. Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain
5. Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain
Joseph Goldberg, MD
Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai.
He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 180 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications” published in 2012 by American Psychiatric Publishing. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention.
Heinz C. R. Grunze, MD, PhD
From 2007 to 2015, Dr. Grunze was Professor of Clinical Psychiatry at The Institute of Neuroscience at the University of Newcastle upon Tyne in the United Kingdom. From 2015 to 2016, he was Professor of Psychiatry at the Paracelsius Medical University in Salzburg, Austria where he was the Head of the University Department of Psychiatry. Since January 2017 he is Medical Director of the Addiction Services “Evangelische Stadtmission” at Heidelberg, Germany and continues his academic affiliation with the Paracelsius Medical University.
Dr. Grunze’s main research interests include the neurobiology and treatment of bipolar disorder and depression, and the neurobiological effects of antiepileptic drugs and novel antipsychotics. He has received several grants from national and international institutions including a Stanley Foundation International Center Award for clinical studies in bipolar disorder. His research has been published in various internationally-renowned journals.
Dr. Grunze has been very active in the development of International and European practice guidelines. He has been a member of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Bipolar Disorder, the International College of Neuropsychopharmacology (CINP) Task Force on Antidepressant Medication, the International Society for Bipolar Disorders (ISBD) Task Force on Antidepressant Use in Bipolar Disorders.
Henry Nasrallah, MD
Dr. Henry Nasrallah is a widely recognized neuropsychiatrist, neuropharmacologist, educator, and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for 12 years. He then joined the University of Cincinnati College of Medicine as Associate Dean. In October 2013, he joined St. Louis University to chair the Department of Psychiatry and Behavioral Neuroscience.
Dr. Nasrallah’s research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 395 scientific articles, 450 abstracts, 137 editorials, and 12 books. He is Editor-In-Chief of two journals (Schizophrenia Research and Current Psychiatry) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is a fellow in the American College of Neuropsychopharmacology (ACNP), a distinguished fellow of the American Psychiatric Association (APA), and has served as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received the Golden Apple Teaching Award at 4 different universities. He was recently named by the Thomas Reuters Media as one of the world’s most cited investigators. He has received 93 research grants.
Gary Sachs, MD
Dr. Gary Sachs is Associate Clinical Professor in Psychiatry at Harvard Medical School and a Clinical Vice President at Bracket.
Dr. Sachs is the Founding Director of the Bipolar Clinic and Research Program at Massachusetts General Hospital (MGH) and founder of the Collaborative Care Initiative.
As Principal Investigator of the National Institute of Mental Health (NIHM) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), Dr. Sachs led the largest treatment study ever conducted for bipolar disorder.
Dr. Sachs serves on the board of directors for the Depression and Bipolar Support Alliance and Co-chairs the DBSA scientific advisory board. He served on the executive committee of the International Society for CNS Clinical Trial Methodology. He chaired the Scientific Advisory Board for the National Alliance on Mentally Illness and served as Co-editor-in-chief of the Clinical Approaches to Bipolar Disorder as well as the editorial boards of Current Psychiatry, Medscape and the Psychotic Disorders Review, among others. He has authored over 200 articles, abstracts, books, reviews, and book chapters.
Dr. Sachs has received many awards, among them the Thouron Scholarship, Laughlin Fellowship, Dunlop Award for psychiatric research and writing, a Dupont-Warren Fellowship at the Harvard Medical School and the Massachusetts Psychiatric Association Research Award. He is a distinguished fellow of the American Psychiatric Association and is recognized as a “Top Doctor” by US News and World Report, and by Reuters as among the world’s 100 most influential Psychiatrists, Neurologists and Neuroscientists.
As a recipient of an NIH Small Business Innovative Research Grant, he founded Concordant Rater Systems and holds patents for methods to improve endpoint reliability in clinical trials. He currently focuses his work on clinical trial methodology, innovative approaches to clinical practice and patient-centered research.
Michael E. Thase, MD
Michael E. Thase, MD, a member of the Editorial Board of Simple and Practical Mental Health, is internationally renowned as a leading expert on the psychopharmacology of Mood Disorders and in particular, treatment-resistant depression.
Dr. Thase is a Professor of Psychiatry and Director of the Mood and Anxiety Disorders section of the Department of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, Pennsylvania, USA. In addition, he also directs the Mood Disorders Research studies at the Philadelphia Veterans Affairs Medical Center (VAMC).
Previously, Dr. Thase spent more than 27 years at the University of Pittsburgh Medical Center and the Western Psychiatric Institute and Clinic. He is an expert not only on biological treatments of mood disorders but on cognitive therapy as well.
Dr. Thase is the President of the American Society of Clinical Psychopharmacology (2017 to 2019). He is a Distinguished Fellow of the American Psychiatric Association, a Founding Fellow of the Academy of Cognitive Therapy, a member of the Board of Directors of the American Society of Clinical Psychopharmacology, and Vice Chairman of the Scientific Advisory Board of the National Depression and Bipolar Support Alliance. Dr. Thase has been elected to the membership of the American College of Psychiatrists and the American College of Neuropsychopharmacology.
Dr. Thase’s research, which has been continuously funded by the Institutes of the NIH for nearly 30 years, focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder.
Recent research projects have included studies of novel ketamine-like compounds, a multicenter study of the efficacy of rTMS for depressed veterans (funded as a cooperative study by the VHA), a multicenter trial comparing the effectiveness and tolerability of lithium and quetiapine for bipolar depression (funded by AHRQ and conducted as part of the Bipolar Treatment Network), and a large scale noninferiority trial comparing a novel computer-administered form of Cognitive Therapy versus the conventional 20 session/16 week model of treatment (two center trial funded by NIMH, with J. Wright of University of Louisville).
Dr. Thase has authored or co-authored more than 700 scientific articles and book chapters, as well as 16 books.
Mark Zimmerman, MD
Mark Zimmerman is a graduate of Columbia University. Before medical school he worked in the University of Iowa Department of Psychiatry where, as a research assistant, he published more than 50 articles in the psychiatric literature. While in Iowa Dr. Zimmerman developed a self-report questionnaire to diagnose DSM-III major depressive disorder, and was one of the authors of the first semi-structured interview to assess the DSM-III personality disorders.
While a student at Chicago Medical School Dr. Zimmerman conducted a nationwide survey of psychiatrists’ attitudes towards the frequent revisions of the psychiatric diagnostic system, and while studying for his second year boards he had an editorial published in the Archives of General Psychiatry questioning the wisdom of revising the American Psychiatric Association’s Diagnostic and Statistical Manual every few years.
Because of this pre-degree scholarship he was appointed to the faculty at the Medical College of Pennsylvania at the assistant professor level during his residency. As a resident he received an NIMH grant in the area of personality disorder assessment. After residency he went to Brown University where he is currently Professor of Psychiatry and Human Behavior and the Director of Adult Outpatient Psychiatry and the Partial Hospital Program at Rhode Island Hospital.
Dr. Zimmerman is the principal investigator of the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, the largest clinical epidemiology study using semi-structured diagnostic interviews ever conducted. The goal of the MIDAS project has been to integrate research methodology into routine clinical practice in order to improve clinical practice and examine a number of issues related to diagnostic comorbidity and treatment outcome.
Throughout his career, Dr. Zimmerman has maintained a busy clinical practice, and a major focus of his research has been the development of tools that are practical and feasible to incorporate into clinical practice. In 2008 he published a widely discussed study on the overdiagnosis of bipolar disorder. He is the author of more than 400 articles published in peer-reviewed journals. He serves on the editorial board of 11 journals, including associate editor of Psychiatry Research and the Journal of Personality Disorders. He also is the author of the Interview Guide to Diagnose DSM-5 Psychiatric Disorders and the Mental Status Examination.